Dermatology endoscopy devices market seen reaching $3.61 billion by 2030

The dermatology endoscopy devices market is projected to grow from $2.39 billion in 2025 to $3.61 billion by 2030, driven by demand for early skin disease detection, AI-powered analysis and portable diagnostic tools. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Dermatology endoscopy devices are becoming more important as skin disorders rise and clinicians need faster, more accurate tools for early detection. - The market’s expected expansion signals continued investment in non-invasive diagnostics, teledermatology and portable imaging systems.

What happened: - The Business Research Company projected the global dermatology endoscopy devices market will rise from $2.39 billion in 2025 to $2.59 billion in 2026. - The report forecasts the market will reach $3.61 billion by 2030. - The forecast implies an 8.4% CAGR from 2025 to 2026 and an 8.7% CAGR through 2030. - The report was released Aug. 4, 2026. - The company published a free sample of the report.

The details: - Dermatology endoscopy devices use light sources and magnifying lenses to visualize deeper layers of the skin. - The devices help identify skin disorders by examining structures, patterns and lesions with greater clarity. - They are used to diagnose skin abnormalities and support treatment planning. - The report cited rising skin disorder prevalence, greater awareness of early skin cancer detection, wider use of dermatoscopy, expansion of outpatient dermatology services and more handheld diagnostic tools as historical growth drivers. - The forecast period is expected to be supported by demand for AI-powered skin analysis systems, telemedicine adoption, dermatology expansion in emerging economies, portable diagnostic devices and earlier detection of skin conditions. - Key trends cited for the forecast period include digital dermatoscopes, smartphone-connected devices, non-invasive diagnostics, teledermatology and higher-resolution imaging. - The report listed pigmented and non-pigmented lesions, scabies, psoriasis and eczema among conditions evaluated with these devices. - Cancer Australia reported about 8,257 new melanoma cases in 2023, representing 2.6% of all cancer-related deaths in the country. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - Other regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report also includes key technology and future trend analysis. - The company provided contact details for its expert Saumya Sahay and listed social links on LinkedIn, Facebook and X.

Between the lines: - The forecast points to a market shifting from basic visual inspection toward connected, data-driven diagnostic tools. - The emphasis on AI, telemedicine and smartphone integration suggests growth is increasingly tied to workflows that can expand access beyond specialist clinics. - The regional outlook indicates mature demand in North America and faster adoption potential in emerging Asian markets.

What's next: - The market’s pace will likely depend on how quickly providers adopt AI-assisted screening, portable devices and teledermatology. - Broader access to dermatology services in emerging economies could shape the next phase of growth. - Continued focus on early skin cancer detection should keep demand elevated for non-invasive diagnostic tools.

The bottom line: - Dermatology endoscopy devices are moving from niche diagnostic tools to a broader digital screening category, with growth supported by early detection needs and new imaging technology.